FDA Inspection
Hubei Gedian Humanwell Pharmaceutical Co., Ltd.Hubei Gedian Humanwell Pharmaceutical Co., Ltd. – FDA Inspection, Jun 28, 2019
Record Details
This FDA Inspection record concerns Hubei Gedian Humanwell Pharmaceutical Co., Ltd., with an inspection on June 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2f6ace4a-b2c0-45cb-ad49-101d7cd59ffb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1098272
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | OAI | Drug Quality Assurance | |
| May 13, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
- FDA Inspection 1295344 - 2025-11-07
- FDA Inspection 971471 - 2016-05-13
- FDA Inspection 854699 - 2013-10-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.